Blood News and Research

RSS

ADInstruments' latest version of LabTutor helps nursing students

ADInstruments is helping nursing students bridge the gap between the classroom and hospital ward with the latest version of LabTutor and three Nursing Experiment Collections. LabTutor 3.0 supports 19 new experiments (featuring over 100 exercises including patient case studies) that illustrate in practical terms the biological theory taught in nursing anatomy and physiology classrooms.

28 Aug 2009

Study shows younger adults with high cholesterol not adhering to prescribed medications

A study released today by CVS Caremark found that more than 50 percent of patients under the age of 45 who are prescribed a medication to treat high cholesterol are not optimally adherent to their therapy.

28 Aug 2009

Dr. David J. Caparrelli becomes a member of SVS at its Vascular Annual Meeting

Dr. David J. Caparrelli who practices at Arizona Heart Institute (AHI) became an active member of the Society for Vascular Surgery (SVS) during its Vascular Annual Meeting in Denver.

28 Aug 2009

CHI's first symposium to increase the understanding of its role in performing human immunologic studies

NIH’s National Heart, Lung and Blood Institute’s CENTER FOR HUMAN IMMUNOLOGY (CHI) announces the first Meeting the Human Immunology Challenge Symposium. This two-day meeting will be held September 3-4, 2009 on the NIH Campus.

28 Aug 2009

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

28 Aug 2009

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

Despite tough economic times, Copan is proud to announce the expansion of its US operations. Copan Diagnostics, Inc. is undertaking a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing operations to its facility in Murrieta, California.

28 Aug 2009

Distribution agreement signed between Cardiovascular Systems and Asahi Intecc

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd., based in Japan, to market its peripheral guide wire line in the United States.

28 Aug 2009

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

AgaMatrix, Inc., the makers of WaveSense blood glucose meters, announced today their continued commitment to educate health care professionals and patients on the importance of blood glucose meter (BGM) accuracy for all patients.

28 Aug 2009

Scientists discover the vulnerability of old people to cancer and skin infections

Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered why older people may be so vulnerable to cancer and infections in the skin. The team from UCL has shown in human volunteers that defective immunity in the skin is caused by an inability to mobilise essential defences that would otherwise recognise threats and clear them before irreparable damage is done.

28 Aug 2009

Fatostatin lowers the activity of genes associated with cholesterol synthesis

A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell Press journal.

27 Aug 2009

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that warfarin should be prescribed with caution in patients with kidney failure.

27 Aug 2009

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.

27 Aug 2009

Study: Patients may face radioactive risk from imaging tests

"At least four million Americans under age 65 are exposed to high doses of radiation each year from medical imaging tests, according to a new study in The New England Journal of Medicine," The New York Times reports. And about ten percent of those patients "receive very high doses, more than the maximum annual exposure allowed for nuclear power plant employees or anyone else who works with radioactive material." The study was based on a survey of nearly one million patients insured by UnitedHealthcare.

27 Aug 2009

Arrayit supplies instruments for identifying allergens

Arrayit Corporation, a proprietary life sciences technology leader, announces the sale of instruments used to identify allergens in affected individuals.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

ATS Medical, Inc. manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the FDA has approved a landmark clinical study in which cardiac surgeons will implant the ATS 3f(R) Aortic Bioprosthesis in a younger aortic valve replacement patient population that has not been previously studied in a controlled and scientific manner.

27 Aug 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called “EMP Diagnostics Inc.” (“EDI”). The business of the new company will focus on the application of Haber’s Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.

27 Aug 2009

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

27 Aug 2009

Urgent requirement for O negative blood group in Memorial Blood Centers

The need for blood never takes a vacation. Every two seconds, someone in our community needs blood. From premature infants to an organ transplant recipient who will typically require 40 units of blood to survive. And right now, the need is urgent. We are currently facing a shortage of Type 0 negative, the universal blood type that can be given to save the life of anyone, from premature infants and children having heart surgery to an organ transplant recipient who will typically require 40 units of blood to survive. Type B negative blood also is urgently needed.

27 Aug 2009

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

27 Aug 2009

Blood News and Research

ADInstruments' latest version of LabTutor helps nursing students

Study shows younger adults with high cholesterol not adhering to prescribed medications

Dr. David J. Caparrelli becomes a member of SVS at its Vascular Annual Meeting

CHI's first symposium to increase the understanding of its role in performing human immunologic studies

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

Distribution agreement signed between Cardiovascular Systems and Asahi Intecc

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

Scientists discover the vulnerability of old people to cancer and skin infections

Fatostatin lowers the activity of genes associated with cholesterol synthesis

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

Study: Patients may face radioactive risk from imaging tests

Arrayit supplies instruments for identifying allergens

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

Urgent requirement for O negative blood group in Memorial Blood Centers

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News